FIELD: pharmacology.
SUBSTANCE: invention relates to an antibody that specifically binds to the CAPRIN-1 protein, as well as to a conjugate for treatment or prevention of CAPRIN-1 expressing cancer containing it. A pharmaceutical composition for CAPRIN-1 treatment or prevention, as well as a pharmaceutical combination for CAPRIN-1treatment or prevention containing the above antibody or conjugate is also described. The invention also relates to a method for treatment or prevention of a CAPRIN-1 expression cancer comprising administration of the above antibody, conjugate, composition or combination.
EFFECT: invention allows effective treatment or prevention of CAPRIN-1 expressing cancer.
12 cl, 8 ex
| Title | Year | Author | Number |
|---|---|---|---|
| PHARMACEUTICAL COMPOSITION FOR CANCER TREATMENT AND/OR PREVENTION | 2013 |
|
RU2633505C2 |
| PHARMACEUTICAL COMPOSITION FOR CANCER TREATMENT OR PREVENTION | 2013 |
|
RU2631804C2 |
| PHARMACEUTICAL COMPOSITION FOR CANCER TREATMENT AND/OR PREVENTION | 2013 |
|
RU2632645C2 |
| PHARMACEUTICAL COMPOSITION FOR TREATMENT AND/OR PREVENTION OF CANCER | 2011 |
|
RU2607366C2 |
| PHARMACEUTICAL COMPOSITION FOR TREATMENT AND/OR PREVENTION OF CANCER | 2011 |
|
RU2597971C2 |
| PHARMACEUTICAL COMPOSITION FOR TREATMENT AND/OR PREVENTION OF CANCER | 2011 |
|
RU2598258C2 |
| PHARMACEUTICAL COMPOSITION FOR TREATING AND/OR PREVENTING CANCER | 2011 |
|
RU2567657C2 |
| PHARMACEUTICAL COMPOSITION FOR TREATMENT AND/OR PREVENTION OF CANCER | 2014 |
|
RU2678138C2 |
| PHARMACEUTICAL COMPOSITION FOR TREATMENT AND/OR PREVENTION OF CANCER | 2011 |
|
RU2603742C2 |
| PHARMACEUTICAL COMPOSITION FOR CANCER TREATMENT AND PREVENTION | 2012 |
|
RU2641260C2 |
